您好, 访客   登录/注册

二级肿瘤专科医院药品配备的合理性分析

来源:用户上传      作者:钱佳佳 徐蕊 杜琼 翟青 阮聪

  摘 要 目的:根据《抗肿瘤药物临床应用管理办法》分析某二级肿瘤专科医院药物配备和使用情况,促进抗肿瘤药物的合理使用。方法:对分院2019―2020年基本药物,中成药,抗肿瘤药物以及辅助药物的使用数量、金额进行统计,比较其使用情况的变化,并与国家或上海市标准进行比较分析。结果:国家基本药物品种数和使用金额基本符合要求。限制使用级抗肿瘤药物使用金额增加,抗肿瘤辅助治疗药物品种有待改善。结论:分院国家基本药物中抗肿瘤药物配备率有待提升,限制使用级抗肿瘤药物,抗肿瘤辅助药物以及中成药的临床应用有待进一步规范。抗肿瘤药物使用与我国癌症发病率以及分院收治患者人群特征基本一致。
  关键词 基本药物 抗肿瘤药物 药品配备
  中图分类号:R954 文献标志码:C 文章编号:1006-1533(2022)09-0050-04
  引用本文 钱佳佳, 徐蕊, 杜琼, 等. 二级肿瘤专科医院药品配备的合理性分析[J]. 上海医药, 2022, 43(9): 50-53; 62.
  Analysis of the rationality of drug catalogue in secondary cancer specialty hospital
  QIAN Jiajia1, XU Rui1, DU Qiong1,2,3, ZHAI Qing1,2,3, RUAN Cong1
  (1. Department of Pharmacy, Minhang Branch, Shanghai Cancer Center of Fudan University, Shanghai 200240, China; 2. Shanghai Cancer Center of Fudan University, Shanghai 200032, China; 3. Department of Oncology, Shanghai School of Medicine, Fudan University, Shanghai 200433, China)
  ABSTRACT Objective: To analyze the drug allocation and use in a second-level tumor specialist hospital based on the“Administrative Measures for the Clinical Application of Anti-tumor Drugs” and to promote the rational use of anti-tumor drugs. Methods: Statistics on the number and amount of essential medicines, Chinese patent drugs, anti-tumor drugs and auxiliary drugs used in our hospital from 2019 to 2020 were made, the changes in their use were compared and the results were compared with the national or Shanghai standards. Results: The varieties and amounts of national essential medicines were basically met the requirements. The amount of anti-tumor drugs with restricted use grade was increased, and the variety of adjuvant antitumor drugs remained to be improved. Conclusion: The provision rate of anti-tumor drugs in the national essential medicines needs to be improved, the use of anti-tumor drugs with restricted use grade, the clinical application of anti-tumor adjuvant drugs and proprietary Chinese medicines need to be further standardized. The use of anti-tumor drugs is basically consistent with the incidence of cancer in China and the characteristics of patient population admitted to this hospital.
  KEY WORDS essential medicines; anti-tumor drugs; drug catalogue
  根世界卫生组织国际癌症机构(IARC)近日发布的2020年全球最新癌症负担数据,不论是新发还是死亡人数,中国均位居全球第一[1],因此,将癌症预防和治疗纳入卫生计划,将有利于降低未来的癌症负担。随着抗肿瘤药物实行医保谈判和带量采购[2-4]、靶向和免疫治疗药物的降价及医保适应证的扩大而极大地减轻了患者的经济负担,伴随而来的是抗肿瘤药物消耗增速加快、医保控费压力增大及抗肿瘤药物超说明书使用现象频繁等问题。对于这些问题,《抗肿瘤药物临床应用管理办法》中明确指出对医疗机构内抗肿瘤药物的遴选、采购、储存、处方、调配、临床应用和药物评价进行全过程管理,并实行分级管理[5]。

nlc202207272137



转载注明来源:https://www.xzbu.com/6/view-15436848.htm

相关文章

服务推荐